Page last updated: 2024-10-17

bupropion and Premenstrual Syndrome

bupropion has been researched along with Premenstrual Syndrome in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research Excerpts

ExcerptRelevanceReference
"Fluoxetine was superior to both bupropion and placebo."2.68Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. ( Brown, WA; Lund, SA; Pearlstein, TB; Scheft, H; Stone, AB; Zlotnick, C, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pearlstein, TB1
Stone, AB1
Lund, SA1
Scheft, H1
Zlotnick, C1
Brown, WA1

Trials

1 trial available for bupropion and Premenstrual Syndrome

ArticleYear
Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female;

1997